ZOETIS INC CLASS A (ZTS)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ZTS
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ZTS | Former Chief Financial Officer of Wyeth; Independent Director; Chair | 68 | ["Former Chief Financial Officer of Wyeth","Over 20 years of leadership and financial management experience in global healthcare and pharmaceuticals","Exceptional financial and accounting expertise","Knowledge of reporting requirements and disclosure rules","Audit committee responsibilities","Institutional knowledge as chair of the Audit Committee","Expertise in working with internal and external audit teams","Navigating complex financial and compliance matters","Financially Literate","Audit committee financial expert"] | ["Audit","Corporate Governance","Audit Committee","Corporate Governance Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| RPRX | Independent Director; Chair | 68 | ["Former CFO, Wyeth","Leadership","Finance / Accounting","Business Strategy","Technology/Cybersecurity","Risk Management","Managing Director of G9 Capital Group LLC since January 2010","Member of the Investment Committee of Royalty Pharma (2014 to June 2020)","Various senior positions at Wyeth, including Chief Financial Officer from 1989 to 2010","Started career with Arthur Andersen & Company","Chair of Audit Committee","Selected for vast financial and accounting expertise","Broad knowledge of global business operations, finance, leadership, strategy and risk management","Qualified as an audit committee financial expert","financial expert","audit committee experience"] | ["Audit Committee","Nominating and Corporate Governance Committee"] | 2026 |
| PRAX | [] | ["Audit Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Independent Director Former Chief Financial Officer of Wyeth Director since: January 2013 Committees: Audit (Chair); Corporate Governance Age: 68 Other Current Public Company Directorships: Praxis Precision Medicines, Inc. (since March 2019) Royalty Pharma plc (since June 2020) Throughout his tenure at Wyeth, where he had broad responsibilities for many of the company s global functional areas and businesses, and later in his role as corporate CFO at Wyeth, he worked with a broad range of human and animal health businesses, including Fort Dodge Animal Health, a manufacturer of animal health products, that was part of Wyeth, bringing a deep understanding of the industry to the Board. Audit and accounting expertise acquired from experience as Audit Manager at Arthur Andersen & Co., working primarily with multinational companies in the life sciences, consumer products and financial services industries, with a comprehensive knowledge of reporting rules, disclosure requirements and the critical role of external auditors. Deep expertise in creating and executing high impact strategic and operational global corporate initiatives, including as one of the lead architects/negotiators of the $68 billion Pfizer acquisition of Wyeth, which enhances Board discussions on major acquisitions and alliances and the Company s capital allocation strategy. Extensive board experience, currently serving on the board of directors of Praxis Precision Medicines and Royalty Pharma, as well as previous service on the boards of directors of Human Genome Sciences, Welch Allyn, Univision, Entasis, nanoString Technologies and Anthos. Career Highlights: Wyeth (acquired by Pfizer in 2009) a global pharmaceutical and healthcare products company Chief Financial Officer (2007-2009) Executive Vice President and Chief Financial Officer of Wyeth Pharmaceuticals, Inc. (2000-2007) Various senior positions (1989-2000) Arthur Andersen & Co. a global accounting firm Audit Manager (1983-1989) G9 Capital Group LLC provider of corporate advisory services to companies, family offices and leading venture capital and private equity firms Managing Director (2010-2025) Education: Bachelor s degree in Management and Economics from State University of New York at Plattsburgh Master of Science in Accounting from LIU Post